A carregar...
On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
For 50 years ago was introduced L-3,4-dihydroxyphenylalanine (L-dopa) in Parkinson's disease treatment and during this significant advances has been done but what trigger the degeneration of the nigrostriatal system remain unknown. There is a general agreement in the scientific community that m...
Na minha lista:
| Publicado no: | Neural Regen Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5514859/ https://ncbi.nlm.nih.gov/pubmed/28761417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.208560 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|